Clinical trial
Investigation in the Pathogenesis of Liver Disease in Patients With Inborn Errors of Bile Acid Metabolism
NCT00007020 is registered in ClinicalTrials.gov with Mirum Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation in the Pathogenesis of Liver Disease in Patients With Inborn Errors of Bile Acid Metabolism
- Lead sponsor
- Mirum Pharmaceuticals, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 1992
- Completion date
- December 31, 2009
- Enrollment
- 85 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adrenoleukodystrophy, cholestasis, infantile refsum's disease, peroxisomal disorders, zellweger syndrome